TENET HEALTHCARE CORP (THC) FY2026 YTD Q2 Statement of Cash Flows

Income StatementCash FlowBalance Sheet

Statement of Cash Flows

2026-01-01 to 2026-06-30

Swipe to see the full flow
TENET HEALTHCARE CORP cash flow reconciliation, Jan 1, 2026 through Jun 30, 2026One connected Sankey reconciles operating, investing and financing net cash flows through a shared cash pool, from beginning cash to ending cash. Ribbons flow left to right on one dollar scale. Activity totals are dark gray; beginning and ending cash are blue. Cash basis for beginning and ending balances and net cash change: Cash, cash equivalents, and restricted cash. Intermediate calculation bars are lighter gray. Net income is green for profit and red for loss. Identified asset purchases, sales and maturities are blue in either cash direction. Purple identifies capital transactions such as borrowing, repayments, share issuance and dividends. Free cash flow is a separate comparison, not an added cash flow. Read chart description and values below for full signed amounts, including zero items.Net income → Net cash from operating activities: $1,951,000,000.00Depreciation and amortization → Operating adjustments reconciliation: $444,000,000.00Inventories and other current assets → Operating adjustments reconciliation: $249,000,000.00Deferred income tax expense → Operating adjustments reconciliation: $97,000,000.00Income taxes → Operating adjustments reconciliation: $94,000,000.00Stock-based compensation expense → Operating adjustments reconciliation: $69,000,000.00Impairment and restructuring charges, and acquisition-related costs → Operating adjustments reconciliation: $55,000,000.00Other long-term liabilities → Operating adjustments reconciliation: $36,000,000.00Litigation and investigation costs → Operating adjustments reconciliation: $30,000,000.00Amortization of debt discount and debt issuance costs → Operating adjustments reconciliation: $11,000,000.00Operating adjustments reconciliation → Net cash from operating activities: $275,000,000.00Operating adjustments reconciliation → Accounts payable, accrued expenses and other current liabilities: $638,000,000.00Operating adjustments reconciliation → Payments for restructuring charges, acquisition-related costs, and litigation costs and settlements: $84,000,000.00Operating adjustments reconciliation → Net losses (gains) on sales, consolidation and deconsolidation of facilities: $34,000,000.00Operating adjustments reconciliation → Accounts receivable: $33,000,000.00Operating adjustments reconciliation → Equity in earnings of unconsolidated affiliates, net of distributions received: $11,000,000.00Operating adjustments reconciliation → Other items, net: $10,000,000.00Proceeds from sales of marketable securities and long-term investments → investing reconciliation: $51,000,000.00Proceeds from sales of facilities and other assets → investing reconciliation: $6,000,000.00investing reconciliation → Purchases of property and equipment: $348,000,000.00investing reconciliation → Purchases of businesses or joint venture interests, net of cash acquired: $130,000,000.00investing reconciliation → Purchases of marketable securities and long-term investments: $77,000,000.00investing reconciliation → Other items, net: $22,000,000.00Net cash used in financing activities → financing reconciliation: $2,419,000,000.00Proceeds from borrowings → financing reconciliation: $28,000,000.00Proceeds from the sale of noncontrolling interests → financing reconciliation: $15,000,000.00financing reconciliation → Repurchases of common stock: $1,360,000,000.00financing reconciliation → Purchases of noncontrolling interests: $558,000,000.00financing reconciliation → Distributions paid to noncontrolling interests: $398,000,000.00financing reconciliation → Taxes paid related to net share settlement, net of proceeds from shares issued under stock-based compensation plans: $83,000,000.00financing reconciliation → Repayments of borrowings: $59,000,000.00financing reconciliation → Other items, net: $4,000,000.00Net cash used in investing activities → investing reconciliation: $520,000,000.00Beginning cash: Cash, cash equivalents, and restricted cash → Cash sources and uses: $2,883,000,000.00Net cash from operating activities → Cash sources and uses: $2,226,000,000.00Cash sources and uses → Ending cash: Cash, cash equivalents, and restricted cash: $2,170,000,000.00Cash sources and uses → Net cash used in investing activities: $520,000,000.00Cash sources and uses → Net cash used in financing activities: $2,419,000,000.00Depreciation and amortization: $444,000,000.00Depreciation & amortization+$444.00 MDeferred income tax expense: $97,000,000.00Deferred income taxes+$97.00 MStock-based compensation expense: $69,000,000.00Stock-based compensation+$69.00 MImpairment and restructuring charges, and acquisition-related costs: $55,000,000.00Impairment & restructuring costs+$55.00 MAmortization of debt discount and debt issuance costs: $11,000,000.00Debt cost amortization+$11.00 MOther long-term liabilities: $36,000,000.00Other operating liabilities+$36.00 MAccounts payable, accrued expenses and other current liabilities: -$638,000,000.00Payables & accrued liabilities−$638.00 MNet income: $1,951,000,000.00Net income+$1.95 BNet losses (gains) on sales, consolidation and deconsolidation of facilities: -$34,000,000.00Facility gain & loss, net−$34.00 MLitigation and investigation costs: $30,000,000.00Litigation gain & loss+$30.00 MEquity in earnings of unconsolidated affiliates, net of distributions received: -$11,000,000.00Equity-method income, net−$11.00 MOther items, net: -$10,000,000.00Other non-cash items−$10.00 MAccounts receivable: -$33,000,000.00Accounts receivable−$33.00 MInventories and other current assets: $249,000,000.00Inventories & current assets+$249.00 MIncome taxes: $94,000,000.00Income taxes receivable+$94.00 MPayments for restructuring charges, acquisition-related costs, and litigation costs and settlements: -$84,000,000.00Restructuring & litigation paid−$84.00 MNet cash from operating activities: $2,226,000,000.00Operating cash+$2.23 BOperating adjustments reconciliation: $1,085,000,000.00Repayments of borrowings: -$59,000,000.00Debt repaid−$59.00 MProceeds from borrowings: $28,000,000.00Debt issued+$28.00 MRepurchases of common stock: -$1,360,000,000.00Common stock repurchases−$1.36 BDistributions paid to noncontrolling interests: -$398,000,000.00Noncontrolling dividends−$398.00 MProceeds from the sale of noncontrolling interests: $15,000,000.00Noncontrolling interest sales+$15.00 MPurchases of noncontrolling interests: -$558,000,000.00Paid to noncontrolling interests−$558.00 MRepayments of advances from managed care payers: $0.00Taxes paid related to net share settlement, net of proceeds from shares issued under stock-based compensation plans: -$83,000,000.00Stock-award tax withholding−$83.00 MOther items, net: -$4,000,000.00Other financing, net−$4.00 MNet cash used in financing activities: -$2,419,000,000.00. Cash required to fund net payments.Financing cash−$2.42 Bfinancing reconciliation: $2,462,000,000.00Purchases of property and equipment: -$348,000,000.00PP&E purchases−$348.00 MPurchases of businesses or joint venture interests, net of cash acquired: -$130,000,000.00Acquisitions, net of cash−$130.00 MProceeds from sales of facilities and other assets: $6,000,000.00Business sales+$6.00 MProceeds from sales of marketable securities and long-term investments: $51,000,000.00Securities & investment sales+$51.00 MPurchases of marketable securities and long-term investments: -$77,000,000.00Investment purchases−$77.00 MOther items, net: -$22,000,000.00Other investing, net−$22.00 MNet cash used in investing activities: -$520,000,000.00. Cash required to fund net payments.Investing cash−$520.00 Minvesting reconciliation: $577,000,000.00Cash sources and uses: $5,109,000,000.00Beginning cash: Cash, cash equivalents, and restricted cash: $2,883,000,000.00Beginning cash$2.88 BEnding cash: Cash, cash equivalents, and restricted cash: $2,170,000,000.00Ending cash$2.17 BCASH RECONCILIATIONOperatingflowsInvestingflowsFinancingflowsFree cash flow$1.88 BOperating cash − cash spent on PP&ECash flow / Net income1.14×Operating cash flow ÷ net incomeNet cash change−$713.00 MEnding cash − beginning cash
Chart details

TENET HEALTHCARE CORP cash flow reconciliation, Jan 1, 2026 through Jun 30, 2026

Cash flows for Jan 1, 2026 through Jun 30, 2026. Cash basis: Cash, cash equivalents, and restricted cash. Beginning cash: Dec 31, 2025. Ending cash: Jun 30, 2026. Beginning and ending cash are dated balances. Positive cash flows add cash; negative cash flows reduce it.

Beginning cash on Dec 31, 2025
2,883,000,000 US dollars. Beginning cash: Cash, cash equivalents, and restricted cash
Operating activities
2,226,000,000 US dollars. Net cash provided.
Depreciation and amortization
444,000,000 US dollars
Deferred income tax expense
97,000,000 US dollars
Stock-based compensation expense
69,000,000 US dollars
Impairment and restructuring charges, and acquisition-related costs
55,000,000 US dollars
Amortization of debt discount and debt issuance costs
11,000,000 US dollars
Other long-term liabilities
36,000,000 US dollars
Accounts payable, accrued expenses and other current liabilities
negative 638,000,000 US dollars
Net income
1,951,000,000 US dollars
Net losses (gains) on sales, consolidation and deconsolidation of facilities
negative 34,000,000 US dollars
Litigation and investigation costs
30,000,000 US dollars
Equity in earnings of unconsolidated affiliates, net of distributions received
negative 11,000,000 US dollars
Other items, net
negative 10,000,000 US dollars
Accounts receivable
negative 33,000,000 US dollars
Inventories and other current assets
249,000,000 US dollars
Income taxes
94,000,000 US dollars
Payments for restructuring charges, acquisition-related costs, and litigation costs and settlements
negative 84,000,000 US dollars
Investing activities
negative 520,000,000 US dollars. Net cash used.
Purchases of property and equipment
negative 348,000,000 US dollars
Purchases of businesses or joint venture interests, net of cash acquired
negative 130,000,000 US dollars
Proceeds from sales of facilities and other assets
6,000,000 US dollars
Proceeds from sales of marketable securities and long-term investments
51,000,000 US dollars
Purchases of marketable securities and long-term investments
negative 77,000,000 US dollars
Other items, net
negative 22,000,000 US dollars
Financing activities
negative 2,419,000,000 US dollars. Net cash used.
Repayments of borrowings
negative 59,000,000 US dollars
Proceeds from borrowings
28,000,000 US dollars
Repurchases of common stock
negative 1,360,000,000 US dollars
Distributions paid to noncontrolling interests
negative 398,000,000 US dollars
Proceeds from the sale of noncontrolling interests
15,000,000 US dollars
Purchases of noncontrolling interests
negative 558,000,000 US dollars
Repayments of advances from managed care payers
0 US dollars
Taxes paid related to net share settlement, net of proceeds from shares issued under stock-based compensation plans
negative 83,000,000 US dollars
Other items, net
negative 4,000,000 US dollars
Operating adjustment reconciliation
1,085,000,000 US dollars. Intermediate calculation joining the operating reconciliation branches. Its gross amount includes any portion of net income routed through this junction. It is not an additional cash source or use.
financing gross reconciliation
2,462,000,000 US dollars. Gross amount at the activity's junction before offsetting its receipts and deductions. It is not an additional cash source or use.
investing gross reconciliation
577,000,000 US dollars. Gross amount at the activity's junction before offsetting its receipts and deductions. It is not an additional cash source or use.
Exchange-rate effect
0 US dollars
Ending cash on Jun 30, 2026
2,170,000,000 US dollars. Ending cash: Cash, cash equivalents, and restricted cash
Cash sources and uses
5,109,000,000 US dollars. Opening cash plus net sources, equal to net uses plus ending cash.
Net cash change
negative 713,000,000 US dollars. Ending cash minus beginning cash.
Cash flow / Net income
1.14×. Operating cash flow divided by reconciliation net income for the same period. Black from 0.90× through 1.10×; green above 1.10×; red below 0.90×. Color uses the unrounded ratio.
Operating cash flow
2,226,000,000 US dollars. Operating cash flow used in the free cash flow calculation.
Cash purchases of property, plant and equipment
348,000,000 US dollars. These cash purchases are already included in investing activities above.
Free cash flow
1,878,000,000 US dollars. A supplemental measure; finance-lease payments are excluded from this definition.

Chart connections

  • Beginning cash plus operating, investing and financing cash flows plus the exchange-rate effect equals ending cash. Negative amounts reduce cash.
  • Financing contributions meet at a reconciliation junction before connecting to the net cash total.
  • Investing contributions meet at a reconciliation junction before connecting to the net cash total.
  • Operating reconciliation adjustments are not all independent cash receipts.
  • Net income enters operating cash directly in the reconciliation. The adjustment junction contributes the remaining $275.00M after reconciling the other positive and negative adjustments. These connections depict an accounting reconciliation, not traced cash receipts.
  • Each activity has one net cash bar connected to the shared cash pool. Positive activity totals enter the pool; negative activity totals leave the pool to fund that activity's net payments. The central pool does not assign a particular funding source to a particular payment.
  • The intermediate calculation bars include both sides of the displayed activity breakdowns; they are not additional cash flows.
  • Operating cash flow minus cash purchases of property, plant and equipment equals free cash flow: 2,226,000,000 US dollars minus 348,000,000 US dollars equals 1,878,000,000 US dollars.
TENET HEALTHCARE CORP (THC) FY2026 YTD Q2 Statement of Cash Flows Sankey chart
Free to share unchanged, with credit to Plicit.ai · CC BY-NC-ND 4.0Download PNG

Newsletter

Get the teardowns by email

Subscribe if you want the public-company teardowns in your inbox when they're released.

Product waitlist

Health Check and Teardown for your own company

A health check uncovers insights of your private books, not a public ticker. Join this list to get notified as soon as we go-live!